It would appear that there’s been some studies into the relationship between cannabinoids (CBD) and tumours. 

In the late 2010’s / early 2020’s, there has been data found from a number of vitro and in vivo patients with cannabinoids, particularly with cannabidiol (CBD), these have pointed to their potential role as tumour-inhibiting agents.

We’ve so far become aware of nine patients with brain tumours, described as case series, all if these patients received a daily dose of 400 mg of CBD, a standard therapeutic procedure of maximal resection followed by radiochemotherapy. Within a fairly short space of time, most of these patients were survived well, and working towards a full recovery, while surviving longer than the expected average.

Click Here to see what has this to say

Click Here to see what tell us this 

Click Here to see what Medical News Today have said about this

(Return to Physical Health Main page)

(Return to Medical Main page)

Follow Us!